Correction: Casili et al. Therapeutic Potential of BAY-117082, a Selective NLRP3 Inflammasome Inhibitor, on Metastatic Evolution in Human Oral Squamous Cell Carcinoma (OSCC). Cancers 2023, 15, 2796

Cancers (Basel). 2024 Mar 20;16(6):1211. doi: 10.3390/cancers16061211.

Abstract

In the original publication [...].

Publication types

  • Published Erratum